原癌基因AF4蛋白抗体

?原癌基因AF4蛋白抗体Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Proto-oncogene AF-4 (or FEL) is a product of a chromosomal aberration of the human gene AFF1, which is associated with acute leukemias. The fusion of AF-4 on chromosome band 4q21 with the mixed lineage leukemia (MLL or HRX) gene on 11q23 results in a MLL-AF-4 chimeric transcription factor in which原癌基因AF4蛋白抗体 AF-4 contributes transcriptional effector properties and requires cell-specific accessory factors. MLL is involved in several chromosomal translocations associated with acute myeloid and lymphoid leukemia. The MLL-AF-4 fusion protein is expressed in all normal hematopoietic cells. The expression of MLL-AF-4 influences the production of protein cyclin-dependent kinase inhibitor (CDKN1B), suggesting that inhibition of MLL-AF-4 expression may be a powerful and highly specific treatment of chemotherapy-resistant leukemia.

原癌基因AF4蛋白抗体Also known as:

AF 4; AF 4 protein; AF-4 protein; AF4/FMR2 family member 1; AFF 1; AFF1; AFF1_HUMAN; ALL1 fused gene from chromosome 4; ALL1-fused gene from chromosome 4 protein; FEL; MLLT2; MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA TRANSLOCATED TO 2; MLLT2; Protein AF-4; Protein FEL; Proto-oncogene AF4;原癌基因AF4蛋白抗体 AF4; PBM1. .

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Rabbit, .

●

Immunogen: KLH conjugated synthetic peptide derived from human AF 4 protein.

●

Predicted Molecular Weight: 133kDa.

原癌基因AF4蛋白抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl840Hu01凝血因子Ⅸ(F9)多克隆抗体Polyclonal Antibody to Coagulation Factor IX (F9)

kl840Mu01凝血因子Ⅸ(F9)多克隆抗体Polyclonal Antibody to Coagulation Factor IX (F9)

kl840Ra01凝血因子Ⅸ(F9)多克隆抗体Polyclonal Antibody to Coagulation Factor IX (F9)

kl841Mu01含血管性血友病因子A域蛋白1(vWA1)多克隆抗体Polyclonal Antibody to Von Willebrand Factor A Domain Containing Protein 1 (vWA1)

kl842Hu01脂蛋白a(Lpa)多克隆抗体Polyclonal Antibody to Lipoprotein, a (Lpa)

kl846Bo01催乳素(PRL)多克隆抗体Polyclonal Antibody to Prolactin (PRL)

kl846Po01催乳素(PRL)多克隆抗体Polyclonal Antibody to Prolactin (PRL)

kl846Rb51催乳素(PRL)多克隆抗体Polyclonal Antibody to Prolactin (PRL)

kl847Bo01抵抗素(RETN)多克隆抗体Polyclonal Antibody to Resistin (RETN)

kl847Hu01抵抗素(RETN)多克隆抗体Polyclonal Antibody to Resistin (RETN)

kl847Mu01抵抗素(RETN)多克隆抗体Polyclonal Antibody to Resistin (RETN)

kl847Ra01抵抗素(RETN)多克隆抗体Polyclonal Antibody to Resistin (RETN)

kl848Hu01糖原磷酸化酶M(PYGM)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Muscle (PYGM)

kl848Mu01糖原磷酸化酶M(PYGM)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Muscle (PYGM)

kl848Ra01糖原磷酸化酶M(PYGM)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Muscle (PYGM)

kl849Hu01糖原磷酸化酶L(PYGL)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)

kl849Mu01糖原磷酸化酶L(PYGL)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)

kl849Ra01糖原磷酸化酶L(PYGL)多克隆抗体Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)

kl850Hu01肿瘤坏死因子配体超家族成员4(TNFSF4)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 4 (TNFSF4)

kl852Hu01蛋白酶激活受体2(kl2)多克隆抗体Polyclonal Antibody to Protease Activated Receptor 2 (kl2)

kl852Mu01蛋白酶激活受体2(kl2)多克隆抗体Polyclonal Antibody to Protease Activated Receptor 2 (kl2)

kl852Ra01蛋白酶激活受体2(kl2)多克隆抗体Polyclonal Antibody to Protease Activated Receptor 2 (kl2)

kl853Hu01胱天蛋白酶8(CASP8)多克隆抗体Polyclonal Antibody to Caskle 8 (CASP8)